FDA stands against using smartwatches to monitor blood glucose levels
Apple and other tech companies have been working on new non-invasive methods to monitor blood glucose levels through smartwatches and similar devices. However, the U.S. Food and Drug Administration (FDA) has now come out against such technology, claiming that it’s not accurate and could lead to patients being misdiagnosed.
